Rejuvenate Biomed

Rejuvenate Biomed

Biotechnology Research

Diepenbeek, Flemish Region 2,604 followers

We envision a future where people stay healthy for life

About us

Rejuvenate Biomed is a clinical-stage company dedicated to the discovery and development of therapeutics to prevent or delay the onset of multiple age-related diseases. Founded in 2017, Rejuvenate Biomed is a privately-held platform and pipeline company developing safe and proprietary combination drugs that help people healthy for life. By using platform technologies, Rejuvenate Biomed identifies safe compounds that influence the aging process. Novel combination drugs are discovered that have the potential to prevent or delay the onset of multiple age-related diseases. Rejuvenate Biomed confirms prediction data in preclinical models and in clinical studies. Rejuvenate Biomed’s lead drug candidate RJx-01 is currently in Phase 1b for the treatment of sarcopenia, the progressive age-associated loss of muscle function and mass.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Diepenbeek, Flemish Region
Type
Privately Held
Founded
2017
Specialties
Healthcare, Healthspan, Aging, Mouse, Sarcopenia, C. elegans, Research, Drug development, Drug discovery, and Clinical trials

Locations

Employees at Rejuvenate Biomed

Updates

Similar pages

Funding